Sep 18, 2020 / 02:05PM GMT
Geoffrey Christopher Meacham - BofA Securities, Research Division - MD
Okay. Good morning, everyone. I'm Geoff Meacham. I'm the senior biopharma analyst here at Bank of America. I have also for my team, Alec Stranahan. And welcome to the BofA London Healthcare Conference. We have a great session for you today. We have Moderna with us. And speaking on behalf of Moderna, we have CEO, Stéphane Bancel.
So the format for today is just a fireside chat. And we do have access to the Veracast technology. If you want to log in a question, I can see questions in the queue and then I can read those out as well.
So with that, Stéphane, I'll turn it over to you just to kick it off with a couple of -- maybe a recap from yesterday, and we -- and Alec, I can get right into questions after that.
Stephane Bancel - Moderna, Inc. - CEO & Director
Great. Super. Thanks, Geoff, and thanks for having us. So good morning or good afternoon, everybody. I think a quick recap of the Annual R&D Day of Moderna, which happened yesterday. On the vaccine front, we
Moderna Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) Transcript
Sep 18, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers